Sigyn Therapeutics, Inc.

Sigyn Therapeutics, Inc.

SIGY - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$61.33K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Sigyn Therapeutics, Inc.Sigyn Therapeutics, Inc.0-50%--0.4

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$61,332.00
Enterprise Value$3.24 Million
Earnings per Share$-2.09
Beta-0.06
Outstanding Shares2,190,417

Return

Return on Equity49.74%ROE
Return on Assets-7197.69%
Return on Invested Capital35.57%

Valuation & Multiples

P/E Ratio-0.01P/E Ratio
PEG-0.04PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.01Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-1.25
Enterprise Value to Net Income-1
Total Debt to Enterprise0.98
Debt to Equity-0.44Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 20, 2026
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Next Earnings Call

Expected Date
March 3, 2027
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Sigyn Therapeutics, Inc.

4 employees
CEO: James A. Joyce

Sigyn Therapeutics, Inc. operates as a therapeutic technology enterprise currently in its development phase. The company's core innovation is Sigyn Therapy, an advanced blood purification system designed to overcome the limitations of ex...

Questions & Answers